Locacid

Quick links to important sections

Locacid

Selected form

Method of action: Antiacne, Antitumour

Treatment option: Zits, Acne Vulgaris

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Locacid

Property Description
Active Ingredient Tretinoin (All-Trans-Retinoic Acid)
Form Cream or Lotion
Pharmacological Class Retinoid, Topical Anti-acne Agent
Origin Synthetic derivative of Vitamin A
Route Topical (Dermal)

What is the Composition and Classification of Locacid?

Locacid is the trade name for a single-ingredient topical medication whose active substance is Tretinoin, chemically defined as All-Trans-Retinoic Acid. This compound is a highly active member of the retinoid pharmacological class. Tretinoin is recognized on the Model List of Essential Medicines for its dermatological uses, underscoring its established clinical importance. Locacid, being a brand containing only Tretinoin, is typically issued as a prescription-only (Rx-only) medicine.

Tretinoin is a potent derivative of Vitamin A, classified as a synthetic compound that structurally relates to an endogenous human metabolite. As a retinoid, Locacid is primarily categorized as a topical anti-acne agent within its general pharmacological group. This classification reflects the substance’s fundamental role as a cellular regulator.

Locacid: Understanding the Dosage Form and General Purpose

Locacid is typically manufactured as a cream or a lotion, which are both formulations designed for direct topical application onto the skin. The application determines its localized dermal route of administration, contrasting with systemic (oral) retinoid applications.

The general purpose of this medicine is to act as a biological regulator to help restore and maintain the healthy function of the skin. By targeting the skin, Locacid's main function is to modulate the life cycle of skin cells, primarily achieving accelerated epidermal cell turnover and the normalization of cell differentiation within the hair follicles. This mechanism serves the foundational goal of resolving skin issues related to abnormal cell growth and blockage, ultimately improving the overall surface texture.

Regulatory References

  1. WHO Essential Medicines

What side effects are possible with Locacid?

Locacid (Tretinoin topical) is associated with a safety profile primarily defined by local Skin and Subcutaneous Tissue Disorders, as documented in regulatory sources such as the FDA and EMA. The most commonly reported adverse reactions are application-site limited.


Officially Documented Adverse Reactions

The most frequent effects are classified as Very Common or Most Common in official labeling, reflecting an expected cutaneous response:

  • Very Common: Erythema (redness), skin exfoliation (peeling), dry skin, pruritus (itching), and a burning or stinging sensation

.

  • Common: General skin irritation, dermatitis, and localized skin pain.

An exacerbation of inflammatory lesions may be observed during the early weeks of therapy, which is noted as a typical time-related pattern. Symptoms of irritation commonly peak during the initial two weeks of treatment.


Safety Constraints and Special Considerations

The most critical safety restrictions concern external exposure and specific populations. The medicine significantly heightens susceptibility to ultraviolet radiation (photosensitivity). Therefore, official labels mandate minimizing exposure to sunlight and sunlamps.

  • Pregnancy and Lactation: Due to the known risk profile of oral retinoids, official labeling advises that topical Tretinoin should be avoided or used with caution during pregnancy. Caution is also advised during lactation, as it is unknown if the drug is excreted in human milk.
  • Compromised Skin: The product should not be used until the skin has fully recovered from sunburn. Utmost caution is also required when using the product on eczematous skin, as it is reported to cause severe local irritation.

Serious adverse reactions are rare but include severe local reactions (excessive peeling, blistering, crusting) or reactions suggesting hypersensitivity that would necessitate discontinuation.

Overdose and Emergency Response

The official regulatory profile for topical Tretinoin (Locacid) overdose is defined by the potential consequences of two distinct events: excessive application to the skin and the risk of accidental oral ingestion.

Manifestations of Topical Overuse

Excessive dermal application of this product is documented not to accelerate results and may induce significant signs of local irritation. These officially listed manifestations include marked redness (erythema), substantial peeling or exfoliation, and a sensation of discomfort at the site, such as stinging or burning. If severe irritation, blistering, or crusting develops, the regulator-mandated course of action is to temporarily or completely discontinue application.

When to Seek Immediate Medical Help

Immediate medical attention must be sought in the event of accidental oral ingestion of the topical medication. This urgent action is required because oral exposure may result in systemic toxicity with side effects mirroring those associated with excessive oral intake of Vitamin A (Hypervitaminosis A). The management described in official prescribing information is restricted to symptomatic and supportive treatment. Furthermore, official documents confirm that no specific antidote is known for Tretinoin overdose.

Therapeutic Uses of Locacid

What Locacid Treats: Main Uses and Benefits

Locacid (Tretinoin) is commonly used across distinct symptomatic domains, which may help ease the overall symptom burden of certain skin conditions. This medication is applied when support is needed for managing symptoms related to Acne Vulgaris, rough skin texture, fine facial wrinkles, and specific forms of mottled hyperpigmentation (dark spots).

In clinical settings, Locacid is often relevant when supportive symptom management is appropriate for conditions characterized by persistent symptoms associated with follicular congestion and breakouts. Its application assists with managing symptoms related to acne outbreaks and may assist with maintaining functional stability related to the skin's appearance, making it helpful in scenarios requiring additional symptomatic assistance. This use contributes to improved day-to-day comfort and supports general well-being.

Quick Fact: Relief for Congestion Symptoms

This medication is relevant for easing symptoms associated with both blackheads and whiteheads, which are common symptoms of this condition. It also assists with managing symptoms related to uneven skin tone.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Locacid (Tretinoin) eligibility is defined by official regulatory criteria outlining which populations are permitted or prohibited from using the topical medication. Absolute prohibitions for use include individuals with a known hypersensitivity to tretinoin or any of its components. Due to the risk profile of retinoids, the medicine is also contraindicated in pregnant women and women planning a pregnancy, requiring the use of effective contraception during treatment. Furthermore, patients with a personal or familial history of cutaneous epitheliomata (skin cancer) must not use this medicine.

Age restrictions apply, as safety and effectiveness have not been established in children younger than 12 years of age. Similarly, efficacy data are often not established for patients above the age of 65 years. Conditional use applies to specific skin states: treatment must be deferred until recovery from sunburn, and use requires utmost caution on eczematous skin. While there are no absolute contraindications for moderate hepatic or renal impairment, data is not established for severe cases. Caution should also be exercised when the medicine is administered to a nursing mother.

What should I know about interactions with other medicines?

The official interaction profile for Locacid (Tretinoin Topical) is primarily defined by local pharmacodynamic effects, consistent with its minimal systemic absorption as documented in regulatory summaries. Consequently, the official prescribing information does not describe clinically significant systemic drug-drug interactions, such as those mediated by CYP enzymes or drug transporters. There are no systemic combinations formally classified as contraindicated due to pharmacokinetic risk.

Interaction concerns focus on additive effects on the skin. Co-administration with other topical products known to be drying or irritating may result in additive irritancy, leading to increased redness, peeling, or discomfort. This includes preparations such as abrasive cleansers, medicated soaps, astringents, and other anti-acne treatments containing benzoyl peroxide or salicylic acid. Furthermore, topical products containing high concentrations of alcohol, as well as contact with substances like spices or lime, are documented as potential local irritants.

A second documented interaction involves augmented phototoxicity. The use of Locacid with systemic photosensitizing agents, including certain tetracyclines, thiazides, and sulfonamides, increases the risk of severe sun exposure reactions. The regulatory classification requires constraints around administration timing; specifically, the skin must be "rested" until the effects of prior irritating preparations subside before Locacid use is initiated, a rule designed to manage the local irritancy risk documented in the official labeling.

Mechanism of Action

How Locacid Works: Mechanism of Action

Locacid's active ingredient, tretinoin, is a retinoid that modulates cellular activity by acting as an agonist for retinoic acid receptors (RARs) inside the cell nucleus. This interaction directly alters gene transcription in skin cells, primarily keratinocytes and fibroblasts.

Regulating Skin Cell Differentiation and Turnover

This mechanism modifies the genes controlling keratinocyte growth and shedding, reducing the cohesion of cells within the hair follicle. This leads to the expulsion of cellular material and debris from the follicle and influences the organization of the skin's outermost layers.

Modulating Dermal Structural Integrity and Inflammation

Tretinoin stimulates fibroblasts in the dermis to increase the synthesis of structural proteins, including collagen and elastin, while simultaneously influencing the enzymatic breakdown of these components. Furthermore, the drug engages mechanisms that suppress the transcription factors responsible for initiating inflammation, thereby modulating the local output of pro-inflammatory mediators within the tissue.

Dosage and Administration Information

How to Use Locacid: Official Administration Guidelines

Locacid, a brand name for the topical retinoid Tretinoin, is used according to specific instructions to help ensure proper application and absorption. The approved route of administration is topical (dermal), and it must not be used orally, in the eyes (ophthalmic), or intravaginally.


Official Usage Protocol

Instruction Category Official Guideline
Dosing Schedule A thin layer or pea-sized amount is applied to the entire affected skin area. Excessive application is advised against, as it does not enhance results but may lead to irritation.
Frequency Application is typically restricted to once daily, generally in the evening or before bedtime.
Pre-Application The skin must be cleansed with a mild soap and allowed to dry completely. Guidance recommends waiting 20 to 30 minutes after washing before the application is made.

Population and Duration Rules

For pediatric use, topical Tretinoin is generally indicated for children 12 years of age and older for acne, though specific product formulations may be approved for younger ages. Usage for conditions such as fine wrinkles or photoaging is often studied for periods up to 48 weeks of continuous therapy. Initial clinical improvements may be observed in 2 to 3 weeks, but sustained beneficial effects commonly require continued therapy for 7 to 12 weeks.

Procedural Constraints

The medication must be applied with care to avoid sensitive areas, including the eyes, mouth, paranasal creases of the nose, and mucous membranes. If a scheduled dose is missed, patients should simply resume the regular once-daily schedule the following evening, without applying an extra amount.

Recent Clinical Evidence

Research Evidence / Overview of studies for Locacid (Tretinoin)

This overview summarizes the types of clinical studies that have been conducted for Locacid (Tretinoin), detailing the research structure and reported findings without offering clinical advice, dosing information, or safety guidance. The findings describe group patterns observed in research, not personal outcomes.


Research Evidence for Use in Acne Vulgaris

The research base for research involving Locacid for acne is primarily drawn from Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time and often compared Tretinoin against an inactive base (vehicle) or against other active topical treatments. Research focused on study outcomes related to physical discomfort and outcomes linked to inflammatory or irritative states. Studies monitored changes in populations of adolescents and adults with varying degrees of acne severity.

Research highlights changes measured during the study period, reporting how symptoms evolved in the observed populations. Studies report that data show patterns related to change in the number of both inflammatory lesions (like papules and pustules) and non-inflammatory lesions (blackheads and whiteheads) across short-term observation intervals, typically lasting around 12 to 16 weeks.

Research Evidence for Managing Fine Facial Wrinkles and Skin Texture

Research also explored conditions characterized by fluctuating or episodic manifestations associated with photodamage (photoaging). Research examined the study of fine facial wrinkles and rough skin texture. The evidence is drawn from longer-duration, double-blind, vehicle-controlled RCTs and is complemented by meta-analyses. Studies monitored change in fine wrinkling using specialized clinical scales and assessed changes in skin roughness.

Findings describe patterns observed in the studies throughout the long duration of the trials. Data are still emerging on the long-term outcomes and the status of the observed patterns after the study application is ceased.

Research Gaps and Areas of Uncertainty

Findings were mixed or results apply only to the populations studied in several key areas. Research highlights that evidence quality varies across studies, especially regarding the many different available concentrations and formulations of Tretinoin. Data are still emerging on the status of observed patterns over long-term use, and follow-up durations were limited for understanding outcomes beyond a few months for certain indications. Certainty remains limited for outcomes in rare populations or very long-term use.

Key Studies & References

  1. Tretinoin - StatPearls - NCBI Bookshelf (NIH)

Frequently Asked Questions (FAQ)

Common questions about Locacid (FAQ)


Q: What is the difference between Locacid and other common retinoids like tretinoin or adapalene?

Locacid contains the active ingredient Tretinoin, which is one type of topical retinoid derived from Vitamin A. Official regulatory documents indicate Tretinoin and other topical retinoids, such as Adapalene, share similar mechanisms for skin cell regulation. Tretinoin, however, has an official indication for photoaging/fine wrinkles that some others do not. Tretinoin is associated with a common occurrence of initial irritation, which is a known difference cited in clinical literature when compared to other retinoids.


Q: What ingredient should I check for to make sure a moisturizer is safe to use with Locacid?

Official labeling advises caution with topical products that have a strong drying effect or contain high concentrations of ingredients like alcohol, astringents, spices, or lime, as these can increase irritation. Official product information suggests non-comedogenic moisturizers may be beneficial to help manage the common effects of dryness and peeling. The focus should be on avoiding listed irritants.


Q: Can I use products containing benzoyl peroxide or salicylic acid at the same time as Locacid?

Regulatory documents state that co-administration with topical preparations containing Benzoyl peroxide, Salicylic acid, sulfur, or resorcinol may increase the risk of irritation. The product labeling requires caution for these combinations. Official guidance suggests that the skin should be 'rested' until the effects of any prior irritating products subside before Locacid use is initiated.


Q: What is the difference between the different strengths of Locacid available?

Locacid (Tretinoin) is typically available in multiple strengths, such as 0.025%, 0.05%, and 0.1% creams or gels. Official regulatory documents indicate that different strengths are formally indicated for different conditions. For instance, higher concentrations, such as 0.05% or 0.1%, are often indicated for photoaging, while varying strengths are used for acne vulgaris.


Q: What is the 'active metabolite' of the main ingredient in Locacid?

The active ingredient in Locacid is Tretinoin, which is already the active substance. Tretinoin is chemically known as all-trans-retinoic acid, which is a highly active compound and is not a prodrug. Therefore, it does not need to be metabolized by the body to become effective.


Q: Does Locacid have any systemic absorption effects?

Regulatory studies on topical Tretinoin show minimal systemic absorption. Pharmacokinetic data indicates that typically less than 3% of the applied dose is absorbed through the skin. For this reason, official labeling does not describe clinically significant systemic drug-drug interactions, such as those mediated by CYP enzymes.


Q: Is Locacid used for anything besides acne?

Yes, in addition to being indicated for the topical treatment of acne vulgaris, certain formulations of Locacid (Tretinoin) are also officially indicated by regulatory bodies. These secondary indications include use as an adjunctive treatment for mitigating fine facial wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin (photoaging).


Q: Can Locacid be used on sensitive skin?

Official labeling advises that Tretinoin has been reported to cause severe local irritation on eczematous (inflamed) skin and should be used with utmost caution in those with this condition. The medication is also known to commonly cause temporary redness, peeling, and irritation in many users during the initial weeks of treatment. This potential for local irritation is a common consideration when using the product.


Q: Are there any known issues with using Locacid during the summer months?

While the labeling does not specify seasonal use, it strongly mandates minimizing exposure to sunlight and sunlamps. This is because Locacid significantly heightens the skin's susceptibility to ultraviolet radiation (photosensitivity). Official guidance also notes that weather extremes like wind or cold may be particularly irritating to the skin while using this product.


Q: If I stop using Locacid, will the effects immediately reverse?

Regulatory study summaries for photoaging indications indicate that the majority of observed benefits on fine wrinkles and roughness may be gradually lost if the treatment is discontinued. This highlights the importance of the associated sun avoidance program and continued use for sustained outcomes.


Q: Why do people sometimes say that retinoids like Locacid 'purge' the skin?

The term 'purge' refers to the documented, temporary worsening of acne that can occur during the first few weeks of therapy. Official labeling notes that an apparent exacerbation of inflammatory lesions may occur. This observation is noted in official labeling as a common, time-related pattern of response as the medicine begins modulating cell turnover.


Q: Is Locacid available without a prescription in some countries?

In countries with strict regulatory oversight, such as the United States and Canada, Locacid (Tretinoin) is classified as a prescription-only (Rx-only) medication. This means it must be obtained under the supervision of a licensed healthcare professional and cannot be purchased over-the-counter in these regions.


Q: Are there any specific cosmetic procedures or treatments to avoid while using Locacid?

Official labeling strongly cautions against using abrasive cleansers or skin products with high concentrations of alcohol. The skin must also be fully recovered from prior sun exposure or irritation before application. Treatments that cause intentional irritation or inflammation, such as chemical peels or other cosmetic procedures, may require temporary cessation of Locacid.


Q: What are the inactive ingredients often found in Locacid formulations?

The inactive ingredients vary depending on the specific formulation (cream, gel, or lotion) and the manufacturer. Regulatory documents commonly list components such as stearyl alcohol, stearic acid, sorbic acid, butylated hydroxytoluene (BHT), and purified water. These inactive components help ensure the active ingredient is delivered effectively and the product has the proper consistency.


Q: What is the typical patient profile described in studies of Locacid?

Clinical studies supporting the regulatory approval of Locacid (Tretinoin) focused primarily on two patient groups. These were adolescents and adults presenting with varying degrees of acne vulgaris severity, and adults typically under 50 years of age being treated for fine wrinkles and roughness associated with sun damage.


Q: Can men and women use Locacid equally?

Official guidance on Tretinoin does not generally establish differences in efficacy or application protocol between men and non-pregnant women. Use in women who are pregnant or planning pregnancy is addressed by specific contraindications and warnings in the product labeling.


Q: How does the effectiveness of Locacid compare to prescription products containing a different type of retinoid?

Clinical literature suggests Tretinoin may be associated with a higher level of retinoid activity compared to some other topical retinoids like Adapalene for certain indications. This difference in activity can sometimes also be associated with a different profile of initial skin irritation.

How should Locacid be stored and disposed of?

Storage Conditions and Environment

Locacid (Tretinoin) must be stored under specific environmental conditions to maintain its stability, as required by regulatory documents. Tretinoin cream should be stored below 80 F (27 C), while gel formulations are typically stored at controlled room temperature (68 F to 77 F). The product must be protected from light and kept from freezing. Specific gel formulations also carry the warning to keep away from heat and flame due to flammability. The container must be kept tightly closed.

Child-Safety and Disposal

The medication must be stored out of the sight and reach of children. Unused or expired Locacid should be disposed of according to local regulations. General regulatory guidance recommends avoiding disposal in household trash or wastewater when drug take-back options are available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Locacid found in:

A-Z Index: